ASP Isotopes reports the first 18 stages of its Silicon-28 enrichment facility have operated at target levels for over three weeks, following nine months of upgrades to non-core components. Independent analysis confirms enrichment aligns with theory, and ASP has three U.S. contracts with initial shipments targeted for Q3 2026, signaling a near-term revenue ramp and strategic relevance for quantum computing materials.
ASP Isotopes has signed an MOU to assess a long-term partnership for HALEU supply with Quantum Leap Energy. This collaboration aims to enhance nuclear fuel supply and delivery, potentially leading to significant operational projects by 2028, positively impacting ASPI's stock performance and market positioning.
ASP Isotopes' stock rallies following the completion of its Phase 1 drilling ahead of schedule, which shows gas flow rates significantly exceeding prior estimates. With efficient integration into the processing plant expected soon, this momentum could drive further valuation upside.
ASP Isotopes Inc.'s subsidiary, Quantum Leap Energy, signed an MOU with a major U.S. energy firm to establish domestic production of high assay low enriched uranium (HALEU) and low enriched uranium plus (LEU+). This agreement comes at a critical time as the U.S. prepares for a ban on Russian uranium imports in 2028, potentially strengthening ASPI's position in the nuclear supply chain.
ASP Isotopes Inc fell 9% to $12.80 in pre-market trading. The company announced a $250 million mixed shelf offering. Karooooo Ltd missed earnings estimates, impacting market sentiment. Overall, U.S. stock futures were higher this morning. Several other stocks fell sharply in pre-market trading.
